InsiderClue
Insiders · Profile

Saad Mark E

Director at Axsome Therapeutics · Chief Financial Officer at CERENOME. Filing since 12 Aug 2008. CIK 0001295913

AXSM Axsome Therapeutics, Inc. Director · 6 trades CNSY CERENOME, INC. Chief Financial Officer · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AXSM Axsome Therapeutics, Inc.
31 Dec 2025
Director
Sold on a plan
37,577
$6.21M
79.0%
AXSM Axsome Therapeutics, Inc.
5 Sep 2025
Director
Sold on a plan
9,127
$1.14M
47.7%
AXSM Axsome Therapeutics, Inc.
11 Sep 2024
Director
Sold on a plan
11,016
$1.01M
52.4%
AXSM Axsome Therapeutics, Inc.
17 Nov 2021
Director
Bought
3,000
$103.60K
42.8%
AXSM Axsome Therapeutics, Inc.
17 Nov 2021
Director
Bought
300
$10.32K
opened
AXSM Axsome Therapeutics, Inc.
23 May 2019
Director
Bought
3,500
$78.16K
99.9%
CNSY CERENOME, INC.
14 Mar 2012
Chief Financial Officer
Bought
10,000
$25.49K
7.0%
CNSY CERENOME, INC.
12 Aug 2011
Chief Financial Officer
Bought
6,500
$20.29K
5.6%
CNSY CERENOME, INC.
21 May 2010
Chief Financial Officer
Bought
6,000
$25.74K
7.8%
CNSY CERENOME, INC.
12 Aug 2008
Chief Financial Officer
Bought
15,000
$100.31K
24.4%
10 decisions on file.